Zusammenfassung
Seit mehreren Jahren entfallen über 60% der Antiepileptikaverordnungen auf die beiden führenden Wirkstoffe Carbamazepin und Valproinsäure.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., et al. for the Gabapentin Diabetic Neuropathy Study Group (1998): Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 280: 1831–1836.
Beydoun A. (1997): Monotherapy trials of new antiepileptic drugs. Epilepsia 38 (Suppl. 9): S21 - S31.
Beydoun A. (1999): Monotherapy trials with gabapentin for partial epilepsy. Epilepsia 40 (Suppl. 6): S13 - S16.
Charatan E (2002): Doctor sues company over unethical marketing. Brit. Med. J. 324: 1234.
Feely M. (1999): Drug treatment of epilepsy. Brit. Med. J. 318: 106–109.
Gidal B.E., Privitera M.D., Sheth R.D., Gilman J.T. (1999): Vigabatrin: a novel therapy for seizure disorders. Ann. Pharmacother. 33: 1277–1286.
Goa K.L., Ross S.R., Chrisp P. (1993): Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 46: 152–176.
Groß-Selbeck G. (1995): Treatment of „benign“ partial epilepsies of childhood, including atypical forms. Neuropediatrics 26: 45–50.
Heaney D.C., Shorvon S.D., Sander J.W. (1998): An economic appraisal of carbamazepine, lamotrigine, phenytoin and valproate as initial treatment in adults with newly diagnosed epilepsy. Epilepsia 39 (Suppl. 3): S19 - S25.
Hufnagel A., Noachtar S. (1998): Epilepsien and ihre medikamentöse Behandlung. In: Brandt T., Dichgans J., Diener H.C. (Hrsg.): Therapie and Verlauf neurologischer Erkrankungen. 3. Aufl., Kohlhammer, Stuttgart, Berlin, Köln, S. 179–203.
Jette N.J., Marson A.G., Kadir Z.A., Hutton J.L. (2000): Topiramate for drug-resistant partial epilepsy. Cochrane Database Syst. Rev. 2: CD001417.
McKee P.J., Blacklaw J., Forrest G., Gillham R.A., Walker S.M., Connelly D., Brodie M.J. (1994): A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. Br. J. Clin. Pharmacol. 37: 27–32.
Morello C.M., Leckband S.G., Stoner C.P., Moorhouse D.F., Sahagian G.A. (1999): Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch. Intern. Med. 159: 1931–1937.
Stefan H., Halâsz P., Gil-Nagel A., Shorvon S., Bauer G., Ben-Menachem E. et al. (2001): Recent advances in the diagnosis and treatment of epilepsy. Eur. J. Neurol. 8: 519–539.
Visintini D., Calzetti S., Mancia D. (1981): Il barbexaclone nel trattamento delle epilessie. Riv. Patol. Nerv. Ment. 102: 29–37.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schwabe, U. (2003). Antiepileptika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2002. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-11173-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-11173-4_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-43624-9
Online ISBN: 978-3-662-11173-4
eBook Packages: Springer Book Archive